Role of the eNOS-NO System in Regulating the Antiproteinuric Effects of VEGF Receptor 2 Inhibition in Diabetes
Figure 2
eNOS expression, activity, and urinary excretion of nitric oxide metabolites in nondiabetic (control) and diabetic Ren-2 rats at 24 days. (a) eNOS mRNA determined by real-time PCR. (b) Immunoblotting kidney homogenates from control and diabetic Ren-2 rats for total eNOS protein and eNOS Ser1177 phosphorylation (p-eNOS), indicative of enzyme activation. (c) Urinary nitrate/nitrite. ((d) and (e)) Immunohistochemistry for eNOS in kidney sections from control (d) and diabetic (e) Ren-2 rats. Original magnification ×160. AU: arbitrary units. , , and .